Surrozen picks up $50 mln Series B

South San Francisco-based Surrozen Inc., a biopharmaceutical company, has secured $50 million in Series B financing. The investors included Horizons Ventures, Hartford HealthCare Endowment, NS Investment and the Column Group.

Source: Press Release